DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to treat COVID-19 Read more
CSIR-CDRI, Lucknow sign license deal with Marc Labs to develop drug for treating heart attack, stroke Read more
Clinical trials of COVID-19 vaccines and therapeutics demonstrate diverse trends: GlobalData Read more